Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

Corporacion Parc Tauli

Status: Enrolling

Conditions: Hepatitis B

Study type: Observational

Funder types: Other

Identifiers

NCT05446532

2022/5032

Details and patient eligibility

About

HBV infection is a dynamic process with complex interactions between virus replication and the host's immune response. The appearance of anti-HBs after HBV infection generally indicates recovery and immunity to HBV1 infection. However, there are several published studies that describe the coexistence of the marker of chronic infection (HBsAg +) and the marker of functional cure (HBsAc +). There are contradictory studies on whether the coexistence of HBsAg/HBsAc implies a different clinical course.

Enrollment: 120 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all those patients who have been seen in outpatient hepatology consultations and who present positive HBsAg and HBsAc serology simultaneously.

Exclusion criteria

• Hepatitis C or HIV Co-infection

Trial design

120 participants in 1 patient group

Not apply

Description:

None. Just registration epidemiology dates